Study of Pulmonary Infections (Pneumonia) in Kidney Transplant Recipients Admitted to Hospital

The investigators aimed to identify prognosis factors associated with in-hospital complications and assess the epidemiology, management, and outcomes of community-acquired pneumonia in a kidney transplant recipients' cohort. The investigators intend to identify each stay by a national database. Then they will be consulted by 2 clinicians to assert CAP clinical definition. After that radiographic evidence will be reviewed to validate CAP diagnoses. Then clinical data are collected in each center.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Transplant Infection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Reims

Reims, 51092, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

kidney transplant recipients
at least 18 years
admitted to hospital for CAP. Non-inclusion criteria were:

Exclusion criteria

incomplete CAP definition
hospital-acquired pneumonia
another diagnosis explaining the symptoms
patients with non-functional kidney graft

Treatment and study plan

Primary outcomes

In-hospital complications

Time frame: inhospital stay, an average of 30 days

In-hospital death, transfer to intensive care units (ICU) and prolonged stays

Sponsors and collaborators

Lead sponsor

CHU de Reims

Other

Registry information

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Dec 3, 2021
Registry last updated: Sep 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed